Literature DB >> 21753798

Is there evidence for neurotoxicity in the prodromal and early stages of schizophrenia?

Adrienne C Lahti1, Meredith A Reid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21753798      PMCID： PMC3154114          DOI： 10.1038/npp.2011.83

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  8 in total

1.  Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States.

Authors:  Alison R Yung; Hok Pan Yuen; Patrick D McGorry; Lisa J Phillips; Daniel Kelly; Margaret Dell'Olio; Shona M Francey; Elizabeth M Cosgrave; Eoin Killackey; Carrie Stanford; Katherine Godfrey; Joe Buckby
Journal:  Aust N Z J Psychiatry       Date:  2005 Nov-Dec       Impact factor: 5.744

2.  Brain volume changes in the first year of illness and 5-year outcome of schizophrenia.

Authors:  W Cahn; N E M van Haren; H E Hulshoff Pol; H G Schnack; E Caspers; D A J Laponder; R S Kahn
Journal:  Br J Psychiatry       Date:  2006-10       Impact factor: 9.319

Review 3.  Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.

Authors:  Stephanie C Licata; Perry F Renshaw
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

4.  An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis.

Authors:  Ofer Agid; Tamara Arenovich; Gautam Sajeev; Robert B Zipursky; Shitij Kapur; George Foussias; Gary Remington
Journal:  J Clin Psychiatry       Date:  2011-03-08       Impact factor: 4.384

5.  Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia.

Authors:  Meredith A Reid; Luke E Stoeckel; David M White; Kathy B Avsar; Mark S Bolding; N Shastry Akella; Robert C Knowlton; Jan A den Hollander; Adrienne C Lahti
Journal:  Biol Psychiatry       Date:  2010-06-08       Impact factor: 13.382

6.  Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis.

Authors:  Camilo de la Fuente-Sandoval; Pablo León-Ortiz; Rafael Favila; Sylvana Stephano; David Mamo; Jesús Ramírez-Bermúdez; Ariel Graff-Guerrero
Journal:  Neuropsychopharmacology       Date:  2011-04-20       Impact factor: 7.853

7.  Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison.

Authors:  Christos Pantelis; Dennis Velakoulis; Patrick D McGorry; Stephen J Wood; John Suckling; Lisa J Phillips; Alison R Yung; Edward T Bullmore; Warrick Brewer; Bridget Soulsby; Patricia Desmond; Philip K McGuire
Journal:  Lancet       Date:  2003-01-25       Impact factor: 79.321

8.  Elevated striatal dopamine function linked to prodromal signs of schizophrenia.

Authors:  Oliver D Howes; Andrew J Montgomery; Marie-Claude Asselin; Robin M Murray; Isabel Valli; Paul Tabraham; Elvira Bramon-Bosch; Lucia Valmaggia; Louise Johns; Matthew Broome; Philip K McGuire; Paul M Grasby
Journal:  Arch Gen Psychiatry       Date:  2009-01
  8 in total
  6 in total

Review 1.  Glutamate-mediated excitotoxicity in schizophrenia: a review.

Authors:  Eric Plitman; Shinichiro Nakajima; Camilo de la Fuente-Sandoval; Philip Gerretsen; M Mallar Chakravarty; Jane Kobylianskii; Jun Ku Chung; Fernando Caravaggio; Yusuke Iwata; Gary Remington; Ariel Graff-Guerrero
Journal:  Eur Neuropsychopharmacol       Date:  2014-08-01       Impact factor: 4.600

2.  Glutamatergic Metabolites, Volume and Cortical Thickness in Antipsychotic-Naive Patients with First-Episode Psychosis: Implications for Excitotoxicity.

Authors:  Eric Plitman; Raihaan Patel; Jun Ku Chung; Jon Pipitone; Sofia Chavez; Francisco Reyes-Madrigal; Gladys Gómez-Cruz; Pablo León-Ortiz; M Mallar Chakravarty; Camilo de la Fuente-Sandoval; Ariel Graff-Guerrero
Journal:  Neuropsychopharmacology       Date:  2016-06-08       Impact factor: 7.853

3.  A Prospective Longitudinal Investigation of Cortical Thickness and Gyrification in Schizophrenia.

Authors:  Eric A Nelson; Nina V Kraguljac; David M White; Ripu D Jindal; Ah L Shin; Adrienne C Lahti
Journal:  Can J Psychiatry       Date:  2020-02-05       Impact factor: 4.356

Review 4.  Viral infection, inflammation and schizophrenia.

Authors:  Rachel E Kneeland; S Hossein Fatemi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-02-10       Impact factor: 5.067

5.  Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia.

Authors:  Meredith A Reid; Nina V Kraguljac; Kathy B Avsar; David M White; Jan A den Hollander; Adrienne C Lahti
Journal:  Schizophr Res       Date:  2013-05-21       Impact factor: 4.939

6.  Investigating structural subdivisions of the anterior cingulate cortex in schizophrenia, with implications for treatment resistance and glutamatergic levels.

Authors:  Ryo Ochi; Eric Plitman; Raihaan Patel; Ryosuke Tarumi; Yusuke Iwata; Sakiko Tsugawa; Julia Kim; Shiori Honda; Yoshihiro Noda; Hiroyuki Uchida; Gabriel A Devenyi; Masaru Mimura; Ariel Graff-Guerrero; M Mallar Chakravarty; Shinichiro Nakajima
Journal:  J Psychiatry Neurosci       Date:  2022-01-13       Impact factor: 6.186
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.